Publications found:
705
Sort by:
Global Ubenimex Capsules Market Growth 2026-2032
US$ 3,660.00
The global Ubenimex Capsules market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Ubenimex (also known as bestatin)...
January 2026
77 pages
Global Aromatase Inhibitors?AI? Market Growth 2026-2032
US$ 3,660.00
The global Aromatase Inhibitors?AI? market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Aromatase inhibitors are a...
January 2026
161 pages
Global Hydroxyurea Tablets Market Growth 2026-2032
US$ 3,660.00
The global Hydroxyurea Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Hydroxyurea tablets are an oral...
January 2026
114 pages
Global Tamoxifen Drugs Market Growth 2026-2032
US$ 3,660.00
The global Tamoxifen Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Tamoxifen is a selective estrogen r...
January 2026
108 pages
Cancer Immunotherapy Market Forecasts to 2032 - Global Analysis By Type (Immune Checkpoint Inhibitors, Monoclonal Antibodies, Cancer Vaccines, Adoptive Cell Transfer Therapy, Cytokines and Oncolytic Virus Therapy), Treatment Setting, Technology, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Cancer Immunotherapy Market is accounted for $140.63 billion in 2025 and is expected to reach $250.55 billion by 2032 growing at a CAGR of 8.6% during the fore...
January 2026
200 pages
Breast Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Therapy (Chemotherapy (Anthracyclines, Taxanes, Antimetabolites, Others), Hormone Therapy, Immunotherapy, Targeted Therapy, Others), By Hormone Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, Others), By Targeted Therapy (Monoclonal Antibodies, Tyrosine Kinase Inhibitor, Herceptin, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Breast Cancer Therapeutics Market is projected to experience significant growth, rising from a valuation of USD 41.91 billion in 2025 to USD 74.29 billion by 2031, reflecting a compound ann...
January 2026
180 pages
Soft Tissue Sarcoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drugs, Radiation Therapy, Others), By End User (Hospitals, Homecare, Specialty Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Soft Tissue Sarcoma Market is projected to expand from a valuation of USD 1.71 Billion in 2025 to USD 2.78 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 8.44%. Soft ti...
January 2026
180 pages
Cancer Monoclonal Antibodies Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type of Monoclonal Antibody (Murine Antibodies, Chimeric Antibodies, Humanized Antibodies), By Monoclonal Antibody Therapies (Bevacizumab (Avastin), Rituximab (Rituxan), Trastuzumab (Herceptin), Cetuximab (Erbitux), Panitumumab (Vectibix), Other), By Application (Breast Cancer, Blood Cancer, Liver Cancer, Brain Cancer, Colorectal Cancer, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cancer Monoclonal Antibodies Market is projected to expand from USD 99.66 Billion in 2025 to USD 244.95 Billion by 2031, reflecting a compound annual growth rate of 16.17%. These laboratory...
January 2026
181 pages
Biliary Tract Cancers Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Cancer Type (Intrahepatic Cholangiocarcinoma (ICC), Extrahepatic Cholangiocarcinoma, Gallbladder Cancer), By End-User (Hospitals, Specialty Cancer Centres, Ambulatory Surgical Centres, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Biliary Tract Cancers Market is projected to expand from USD 675.69 Million in 2025 to USD 892.63 Million by 2031, achieving a compound annual growth rate (CAGR) of 4.75%. This sector compr...
January 2026
180 pages
Cancer Biological Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Cancer Growth Blockers, Monoclonal Antibodies, Vaccines), By Distribution Channel (Hospitals, Retail & Mail Order Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cancer Biological Therapy Market is projected to expand from USD 116.12 Billion in 2025 to USD 182.03 Billion by 2031, achieving a compound annual growth rate of 7.78%. Cancer biological th...
January 2026
180 pages
Chemotherapy-Induced Anemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Mild Anemia, Moderate Anemia, Severe Anemia), By Treatment Type (RBC Transfusions, Erythropoiesis-stimulating agents (ESAs), Iron Supplementation), By Drug Type (Epogen Injection, Procrit Injection, Androxy Oral, Aranesp injection, Epoetin Alfa Injection, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Chemotherapy-Induced Anemia Market is projected to expand from USD 2.86 Billion in 2025 to USD 4.33 Billion by 2031, reflecting a compound annual growth rate of 7.16%. Therapeutics within t...
January 2026
185 pages
Malignant Mesothelioma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Pemetrexed, Cisplatin, Carboplatin, Gemcitabine, Vinorelbine, Others), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Cancer Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Malignant Mesothelioma Therapeutics Market is projected to expand from USD 260.62 Million in 2025 to USD 382.21 Million by 2031, registering a compound annual growth rate of 6.59%. This mar...
January 2026
185 pages
Non-Small Cell Lung Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma), By Treatment (Chemotherapy, Immunotherapy, Radiation Therapy, Surgery, Targeted Therapy Drugs), By Drug Class (Angiogenesis Inhibitor, Epidermal Growth Factor Receptor Blocker, Kinase Inhibitor, Microtubule Stabilizer, Folate Antimetabolites, PD-1/ PD-L1 Inhibitor), By End-User (Hospitals & Clinics, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Non-Small Cell Lung Cancer Market is projected to expand from USD 20.02 Billion in 2025 to USD 36.86 Billion by 2031, reflecting a CAGR of 10.71%. This market encompasses the development an...
January 2026
186 pages
Pituitary Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Cancer Type (Pituitary Adenoma (Benign Tumor), Pituitary Carcinoma (Malignant Tumor)), By Hormone Type (Prolactinoma, Growth Hormone-Secreting Tumor (Acromegaly), Adrenocorticotropic Hormone-Secreting Tumor (Cushings Disease), Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma), Gonadotropin-Secreting Tumor), By Treatment Type (Surgery, Radiation Therapy, Medications, Targeted Therapy, Chemotherapy), By End User (Hospitals, Specialty Clinics, Cancer Treatment Centers, Research Institutes), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Pituitary Cancer Market is projected to expand significantly, rising from USD 476.55 Million in 2025 to USD 843.32 Million by 2031, reflecting a compound annual growth rate of 9.98%. This s...
January 2026
185 pages
Wilms Tumor Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Favorable Histology, Anaplastic Histology), By Treatment (Surgery, Chemotherapy, Radiation Therapy, Others), By End User (Hospitals, Cancer Research Centers, Academic and Research Institutes, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Wilms Tumor Treatment Market is projected to expand from USD 1.64 Billion in 2025 to USD 2.17 Billion by 2031, growing at a CAGR of 4.78%. This market encompasses specialized medical interv...
January 2026
180 pages
Laryngeal Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Biologics, Small Molecules), By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Laryngeal Cancer Therapeutics Market is projected to expand from USD 4.09 Billion in 2025 to USD 5.36 Billion by 2031, registering a compound annual growth rate of 4.61%. This sector compri...
January 2026
180 pages
mTOR Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Rapamune, Afinitor, Torisel, Zortress, Other), By Indication (Oncology, Immunosuppressant, Organ Transplantation, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global mTOR Inhibitors Market is projected to expand from a valuation of USD 4.56 Billion in 2025 to USD 6.46 Billion by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 5.98%. These pharm...
January 2026
180 pages
Myelodysplastic Syndrome (MDS) Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Stem Cell Transplant, Immune Treatments, Chemotherapy, Immunomodulatory Drugs, Anti-anemics, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Myelodysplastic Syndrome (MDS) Treatment Market is projected to expand from USD 3.04 Billion in 2025 to USD 4.33 Billion by 2031, reflecting a compound annual growth rate of 6.07%. Treatmen...
January 2026
180 pages
Intraoperative Radiation Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Intraoperative Radiation Therapy Devices, Intraoperative Radiation Therapy Accessories, and Software and Services), By Method (Electron, Intraoperative Brachytherapy, High Dose-Rate, X-Ray, Others), By Application (Breast Cancer, Brain Tumor, Head and Neck Cancer, Soft Tissue Sarcoma, Pediatric Tumors, Gynecological Cancer, Genitourinary Cancers, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Intraoperative Radiation Therapy Market is projected to grow from USD 56.22 Million in 2025 to USD 77.74 Million by 2031, achieving a CAGR of 5.55%. Intraoperative Radiation Therapy (IORT)...
January 2026
181 pages
Cancer Biologics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Monoclonal Antibodies, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy, Immune Checkpoint Inhibitors), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cancer Biologics Market is projected to grow from USD 100.86 Billion in 2025 to USD 152.81 Billion by 2031, expanding at a CAGR of 7.17%. Cancer biologics are therapeutic agents derived fro...
January 2026
181 pages
Cancer Nanotechnology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Nanoparticles, Nanofibers, Nanorods, Graphene, Nanofluidic Devices, Others), By Application (Breast Cancer, Stomach Cancer, Lung Cancer, Others), By End User (Diagnostics, Therapeutics, Theranostics), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cancer Nanotechnology Market is projected to expand significantly, rising from a valuation of USD 38.05 Billion in 2025 to USD 65.05 Billion by 2031, reflecting a compound annual growth rat...
January 2026
180 pages
Checkpoint Inhibitor Refractory Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (PD-1 Inhibitor, PD-L1 Inhibitor, Others), By Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin Lymphoma, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Checkpoint Inhibitor Refractory Cancer Market is projected to expand from USD 35.25 billion in 2025 to USD 57.48 billion by 2031, registering a CAGR of 8.49%. This market comprises therapeu...
January 2026
185 pages
Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Erlotinib, Afatinib, Gefitinib, Osimertinib, Dacomitinib), By Distribution Channel (Online, Offline),By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer Market is projected to increase from USD 214.58 Million in 2025 to USD 326.38 Million by 2031, expanding at a CAGR of 7.24%. This...
January 2026
186 pages
PD-1 Resistant Head and Neck Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Cytotoxic Agents, EGFR Inhibitors, PD-1 Inhibitors, Pipeline Drugs), By End User (Hospitals, Clinics, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global PD-1 Resistant Head and Neck Cancer Market is projected to expand from USD 1.31 Billion in 2025 to USD 2.25 Billion by 2031, registering a CAGR of 9.43%. Therapies in this sector involve se...
January 2026
180 pages
Oral Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast Segmented By Type (Squamous Cell Carcinoma, Verrucous Carcinoma, Minor Salivary Gland Carcinomas, Lymphomas, others), By Treatment (Targeted Therapy, Chemotherapy, Immunotherapy), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Oral Cancer Treatment Market is projected to expand from USD 2.38 Billion in 2025 to USD 3.22 Billion by 2031, reflecting a compound annual growth rate of 5.17%. This sector encompasses a v...
January 2026
182 pages
Glioma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease (Astrocytoma, Oligoastrocytoma, Oligodendroglioma), By Treatment Type (Surgery, Chemotherapy, Radiation Therapy, Others), By Grade (Low Grade, High Grade), By End user (Hospital & Clinics, Ambulatory Surgical Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Glioma Treatment Market is projected to expand from a valuation of USD 9.34 Billion in 2025 to USD 14.78 Billion by 2031, reflecting a CAGR of 7.95%. This sector encompasses therapeutic int...
January 2026
181 pages
Image-Guided Radiation Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (4D RT, LINAC, MRI-guided radiotherapy, Portal CT Imaging), By Procedure (IMRT, Stereotactic, Particle), By Application (Neck, Prostate, Breast cancer), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Image-Guided Radiation Therapy Market is projected to expand from USD 2.02 Billion in 2025 to USD 2.78 Billion by 2031, registering a compound annual growth rate of 5.45%. This advanced tre...
January 2026
181 pages
Oncolytic Virotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Virus Type (Genetically Engineered Oncolytic Virus, Oncolytic Wild Type Virus), By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer, Pancreatic Cancer, Others), By End User (Hospitals & Clinics, Cancer Research Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Oncolytic Virotherapy Market is projected to expand from USD 49.73 Million in 2025 to USD 153.31 Million by 2031, registering a CAGR of 20.64%. This specialized field of cancer treatment ut...
January 2026
180 pages
Particle Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Proton therapy, Heavy-ion therapy), By System (Multi-room systems, Single-room systems), By Application (Treatment application, Research application), By Cancer-type (Pediatric Cancer, Lung Cancer, Breast cancer, Other cancers), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Particle Therapy Market is projected to expand from USD 999.21 Million in 2025 to USD 1362.93 Million by 2031, reflecting a compound annual growth rate of 5.31%. This specialized form of ex...
January 2026
185 pages
Skin Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Melanoma, Non-melanoma), By Treatment (Chemotherapy, Immunotherapy, Targeted Therapy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Skin Cancer Therapeutics Market is projected to expand from USD 6.89 Billion in 2025 to USD 10.51 Billion by 2031, reflecting a compound annual growth rate of 7.29%. This market encompasses...
January 2026
180 pages
Hyperthermia Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device Type (Microwave Hyperthermia Device, Ultrasound Hyperthermia Device, Infrared Hyperthermia Device, Short-wave Hyperthermia Device), By Application (Prostate Cancer, Breast Cancer, Cervical Cancer, Skin Cancer, Other Cancers), By End User (Hospitals & Clinics, Specialty Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Hyperthermia Cancer Treatment Market is projected to expand from USD 201.25 Million in 2025 to USD 284.19 Million by 2031, registering a CAGR of 5.92%. Hyperthermia therapy involves raising...
January 2026
185 pages
Acute Lymphocytic Leukemia Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Chemotherapy, Hyper-CVAD, CALGB 8811 regimen, Linker regimen, Nucleoside Metabolic Inhibitors, Oncaspar, Targeted therapy, Radiation Therapy, Stem cell transplantation), By Type (Philadelphia chromosome, Precursor B-cell ALL, T-cell ALL), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Acute Lymphocytic Leukemia Therapeutics Market is projected to expand from USD 4.21 Billion in 2025 to USD 5.99 Billion by 2031, reflecting a compound annual growth rate of 6.05%. This mark...
January 2026
182 pages
Invasive Ductal Carcinoma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy, Immunotherapy), By Type (Hormone Receptor, HER2+), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Invasive Ductal Carcinoma Treatment Market will grow from USD 8.67 Billion in 2025 to USD 13.93 Billion by 2031 at a 8.22% CAGR. The Global Invasive Ductal Carcinoma Treatment Market involv...
January 2026
180 pages
NUT Midline Carcinoma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Others), By Route Of Administration (Oral, Intravenous (IV), Other), By End-Use (Hospitals, Specialty Clinics, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global NUT Midline Carcinoma Treatment Market is projected to expand from USD 20.11 Billion in 2025 to USD 33.65 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 8.96%. This sec...
January 2026
180 pages
Epithelioma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Basal Cell Epithelioma, Squamous Cell Epithelioma, Other Epitheliomas), By Drug Class (Hedgehog Pathway Inhibitors, Immune Checkpoint Inhibitors, Chemotherapeutic Agents, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Epithelioma Treatment Market is projected to expand from a valuation of USD 5.22 Billion in 2025 to USD 8.75 Billion by 2031, progressing at a CAGR of 8.99%. This market centers on therapeu...
January 2026
185 pages
Robotic Radiotherapy Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Radiotherapy Systems, Software, 3D Cameras (Surface Guided), Others), By Technology (Linear Accelerators, Conventional Linear Accelerators, MRI - Linear Accelerators, Stereotactic Radiation Therapy Systems, Cyberknife, Gamma Knife, Particle Therapy, Proton Beam Therapy, Heavy Ion beam Therapy), By Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, Colorectal Cancer, Other), By End User (Hospitals, Independent Radiotherapy Centers), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Robotic Radiotherapy Market is projected to expand from USD 2.04 Billion in 2025 to USD 3.82 Billion by 2031, registering a CAGR of 11.02%. This sector involves medical systems that use rob...
January 2026
180 pages
Follicular Thyroid Cancer Drug Sales Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Papillary Carcinoma, Follicular Carcinoma, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Follicular Thyroid Cancer Drug Sales Market is projected to expand from USD 0.76 Billion in 2025 to USD 1.07 Billion by 2031, registering a CAGR of 5.81%. This market sector primarily consi...
January 2026
180 pages
Small Cell Lung Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy Type (Immunotherapy, Targeted Therapy, Chemotherapy), By Drug Type (Atezolizumab, Topotecan, Lurbinectedin, Durvalumab, Methotrexate side, Pembrolizumab), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Small Cell Lung Cancer Therapeutics Market is projected to expand significantly, rising from USD 6.91 Billion in 2025 to USD 12.75 Billion by 2031, reflecting a compound annual growth rate...
January 2026
180 pages
Docetaxel Trihydrate API Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Purity ? 99%, Purity < 99%), By Application (Oncology, Research and Development, Others), By End-User (Pharmaceutical Companies, Research Institutes, Contract Manufacturing Organizations), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Docetaxel Trihydrate API Market is projected to expand from USD 1.45 Billion in 2025 to USD 2.11 Billion by 2031, registering a CAGR of 6.45%. This active pharmaceutical ingredient is a tax...
January 2026
180 pages
Mantle Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnosis (Laboratory exams, Imaging Tests, Bone marrow Biopsy, Others), By Treatment (Diagnosis {Imaging Tests, Surgical Examination, Others}, Therapy{Chemotherapy, Targeted therapy, Immunotherapy, Stem Cell Transplantation, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Mantle Cell Lymphoma Market is projected to expand from USD 2.71 Billion in 2025 to USD 4.28 Billion by 2031, registering a CAGR of 7.91%. This rare and aggressive B-cell malignancy, marked...
January 2026
181 pages
Head and Neck Cancer Therapeutics Market- Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Type (Diagnostic Methods, Treatment Type), By Diagnostic Methods (Biopsy, Imaging, Endoscopy, Others), By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), By Disease Indication (Lip and Oral Cavity Cancer, Laryngeal Cancer, Oropharyngeal Cancer, Salivary Gland Cancer, Nasopharyngeal Cancer, Hypopharyngeal Cancer), By Route of Administration (Injectable, Oral), By Therapeutic Class (PD Inhibitors, EGFR Inhibitors, Microtubule Inhibitors), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Head and Neck Cancer Therapeutics Market is projected to expand significantly, rising from USD 2.38 Billion in 2025 to USD 4.91 Billion by 2031, reflecting a compound annual growth rate of...
January 2026
182 pages
Leukemia Therapeutics Market ? Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia, Others), By Gender (Male, Female), By Age Groups (0-15, 15-30, 30-50, 50+), By Diagnosis (Blood Test, Biopsy, Physical Exam, Imaging), By Treatment (Chemotherapy, Stem Cell Transplantation, Immunotherapy, Targeted Therapy, Others), By Drugs (Tyrosine Kinase Inhibitors, Antimetabolites, Hormones (Corticosteroids), Monoclonal Antibodies, Others), By Route of Administration (Oral, Parenteral), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Leukemia Therapeutics Market is projected to expand from USD 16.51 Billion in 2025 to USD 26.95 Billion by 2031, achieving a CAGR of 8.51%. These therapeutics comprise a wide range of medic...
January 2026
182 pages
Liver Cancer Therapeutics Market ? Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Cancer Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Liver Metastasis, Hepatoblastoma, Angiosarcoma), By Therapy (Targeted Therapy, Radiation and Chemotherapy Therapy, Immunotherapy, Others), By Equipment (Computed Radiography, MRI, Sonography, Others), By Age (0-18, 18-35, 35-50, 50+), By Factors (Non-Alcoholic Fatty Liver Disease, Cirrhosis, Excessive Liver Consumption, Others), By Route of Administration (Oral, Intra-Venous, Others ), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Liver Cancer Therapeutics Market is projected to expand from USD 4.11 Billion in 2025 to USD 6.94 Billion by 2031, reflecting a CAGR of 9.12%. This market encompasses pharmacological interv...
January 2026
180 pages
